J&J To Pay $400M Over Criminal Charge In Risperdal Case

Law360, Philadelphia (November 7, 2013, 9:01 PM EST) -- A Pennsylvania federal judge on Thursday approved a $400 million criminal penalty against Johnson & Johnson unit Janssen Pharmaceuticals Inc., part of a larger $2.2 billion settlement announced Monday, after the company formally admitted to improperly encouraging doctors to use Risperdal to treat dementia.

U.S. District Judge Timothy Savage approved the sentence for one criminal misdemeanor charge of introducing a misbranded drug into interstate commerce, noting that the company's conduct had far greater consequences than those acknowledged in the plea.

“The company compromised the integrity of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.